Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Two distinct HLA-A * 0101 -specific submotifs illustrate alternative peptide binding modes

Identifieur interne : 003D04 ( Main/Exploration ); précédent : 003D03; suivant : 003D05

Two distinct HLA-A * 0101 -specific submotifs illustrate alternative peptide binding modes

Auteurs : Akihiro Kondo ; John Sidney [États-Unis] ; Scott Southwood [États-Unis] ; Marie-France Del Guercio [États-Unis] ; Ettore Appella [États-Unis] ; Hiroshi Sakamoto [États-Unis] ; Howard M. Grey [États-Unis] ; Esteban Celis [États-Unis] ; Robert W. Chesnut [États-Unis] ; Ralph T. Kubo [États-Unis] ; A. Sette [États-Unis]

Source :

RBID : ISTEX:9F7F48931D968B27B427B44991B0FF1D3C92E2CF

Abstract

Abstract:  Previous studies have defined two different peptide binding motifs specific for HLA-A * 0101. These motifs are characterized by the presence of tyrosine (Y) at the C-termini of 9-mer and 10-mer peptides, and either a small polar or hydrophobic (S, T, M) residue in position 2, or a negatively charged (D or E) residue in position 3. In this study, the structural requirements for peptide binding to A * 0101 have been further analyzed by examining the binding capacity of large sets of peptides corresponding to naturally occurring sequences which bore one or the other of these two A * 0101-specific motifs. By correlating the presence of specific residue types at each position along the peptide sequence with increased (or decreased) binding affinity, the prominent influence of secondary anchor residues was revealed. In most cases, the two anchors in positions 2 and 3 appear to act synergistically. With the exception of the DE3 submotif in 9-mer peptides, a positive role for aromatic residues in position 1 and the center of the peptide (positions 4 or 5 of 9- or 10-mer peptides, respectively), and proline at C-3, were also consistently detected. However, secondary anchor residues also appear to differ significantly between the two different submotifs, demonstrating that A * 0101 can utilize alternative modes in binding its peptide ligands. According to these analyses, specific refined submotifs were also established, and their merit verified by independent sets of potential A * 0101 binding peptides. Besides providing useful insight into the nature of the interaction of the A * 0101 allele with its peptide ligands, such refined motifs should also facilitate accurate prediction of potential A * 0101-restricted peptide epitopes.

Url:
DOI: 10.1007/s002510050200


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Two distinct HLA-A * 0101 -specific submotifs illustrate alternative peptide binding modes</title>
<author>
<name sortKey="Kondo, Akihiro" sort="Kondo, Akihiro" uniqKey="Kondo A" first="Akihiro" last="Kondo">Akihiro Kondo</name>
</author>
<author>
<name sortKey="Sidney, John" sort="Sidney, John" uniqKey="Sidney J" first="John" last="Sidney">John Sidney</name>
</author>
<author>
<name sortKey="Southwood, Scott" sort="Southwood, Scott" uniqKey="Southwood S" first="Scott" last="Southwood">Scott Southwood</name>
</author>
<author>
<name sortKey="Del Guercio, Marie France" sort="Del Guercio, Marie France" uniqKey="Del Guercio M" first="Marie-France" last="Del Guercio">Marie-France Del Guercio</name>
</author>
<author>
<name sortKey="Appella, Ettore" sort="Appella, Ettore" uniqKey="Appella E" first="Ettore" last="Appella">Ettore Appella</name>
</author>
<author>
<name sortKey="Sakamoto, Hiroshi" sort="Sakamoto, Hiroshi" uniqKey="Sakamoto H" first="Hiroshi" last="Sakamoto">Hiroshi Sakamoto</name>
</author>
<author>
<name sortKey="Grey, Howard M" sort="Grey, Howard M" uniqKey="Grey H" first="Howard M." last="Grey">Howard M. Grey</name>
</author>
<author>
<name sortKey="Celis, Esteban" sort="Celis, Esteban" uniqKey="Celis E" first="Esteban" last="Celis">Esteban Celis</name>
</author>
<author>
<name sortKey="Chesnut, Robert W" sort="Chesnut, Robert W" uniqKey="Chesnut R" first="Robert W." last="Chesnut">Robert W. Chesnut</name>
</author>
<author>
<name sortKey="Kubo, Ralph T" sort="Kubo, Ralph T" uniqKey="Kubo R" first="Ralph T." last="Kubo">Ralph T. Kubo</name>
</author>
<author>
<name sortKey="Sette, A" sort="Sette, A" uniqKey="Sette A" first="A." last="Sette">A. Sette</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9F7F48931D968B27B427B44991B0FF1D3C92E2CF</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1007/s002510050200</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-FMHWBJDZ-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000145</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000145</idno>
<idno type="wicri:Area/Istex/Curation">000145</idno>
<idno type="wicri:Area/Istex/Checkpoint">001480</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001480</idno>
<idno type="wicri:doubleKey">0093-7711:1997:Kondo A:two:distinct:hla</idno>
<idno type="wicri:Area/Main/Merge">003D59</idno>
<idno type="wicri:Area/Main/Curation">003D04</idno>
<idno type="wicri:Area/Main/Exploration">003D04</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Two distinct HLA-A * 0101 -specific submotifs illustrate alternative peptide binding modes</title>
<author>
<name sortKey="Kondo, Akihiro" sort="Kondo, Akihiro" uniqKey="Kondo A" first="Akihiro" last="Kondo">Akihiro Kondo</name>
<affiliation>
<wicri:noCountry code="subField">JP</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Sidney, John" sort="Sidney, John" uniqKey="Sidney J" first="John" last="Sidney">John Sidney</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Southwood, Scott" sort="Southwood, Scott" uniqKey="Southwood S" first="Scott" last="Southwood">Scott Southwood</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Del Guercio, Marie France" sort="Del Guercio, Marie France" uniqKey="Del Guercio M" first="Marie-France" last="Del Guercio">Marie-France Del Guercio</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Appella, Ettore" sort="Appella, Ettore" uniqKey="Appella E" first="Ettore" last="Appella">Ettore Appella</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bldg. 37, Room 1B04, Bethesda, MD, 20892, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sakamoto, Hiroshi" sort="Sakamoto, Hiroshi" uniqKey="Sakamoto H" first="Hiroshi" last="Sakamoto">Hiroshi Sakamoto</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bldg. 37, Room 1B04, Bethesda, MD, 20892, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Grey, Howard M" sort="Grey, Howard M" uniqKey="Grey H" first="Howard M." last="Grey">Howard M. Grey</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, San Diego, CA, 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Celis, Esteban" sort="Celis, Esteban" uniqKey="Celis E" first="Esteban" last="Celis">Esteban Celis</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chesnut, Robert W" sort="Chesnut, Robert W" uniqKey="Chesnut R" first="Robert W." last="Chesnut">Robert W. Chesnut</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kubo, Ralph T" sort="Kubo, Ralph T" uniqKey="Kubo R" first="Ralph T." last="Kubo">Ralph T. Kubo</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sette, A" sort="Sette, A" uniqKey="Sette A" first="A." last="Sette">A. Sette</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cytel Corporation, 3525 John Hopkins Ct., San Diego, CA 92121, USA</wicri:regionArea>
<wicri:noRegion>USA</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Immunogenetics</title>
<title level="j" type="abbrev">Immunogenetics</title>
<idno type="ISSN">0093-7711</idno>
<idno type="eISSN">1432-1211</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="1997-01-01">1997-01-01</date>
<biblScope unit="volume">45</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="249">249</biblScope>
<biblScope unit="page" to="258">258</biblScope>
</imprint>
<idno type="ISSN">0093-7711</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0093-7711</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract:  Previous studies have defined two different peptide binding motifs specific for HLA-A * 0101. These motifs are characterized by the presence of tyrosine (Y) at the C-termini of 9-mer and 10-mer peptides, and either a small polar or hydrophobic (S, T, M) residue in position 2, or a negatively charged (D or E) residue in position 3. In this study, the structural requirements for peptide binding to A * 0101 have been further analyzed by examining the binding capacity of large sets of peptides corresponding to naturally occurring sequences which bore one or the other of these two A * 0101-specific motifs. By correlating the presence of specific residue types at each position along the peptide sequence with increased (or decreased) binding affinity, the prominent influence of secondary anchor residues was revealed. In most cases, the two anchors in positions 2 and 3 appear to act synergistically. With the exception of the DE3 submotif in 9-mer peptides, a positive role for aromatic residues in position 1 and the center of the peptide (positions 4 or 5 of 9- or 10-mer peptides, respectively), and proline at C-3, were also consistently detected. However, secondary anchor residues also appear to differ significantly between the two different submotifs, demonstrating that A * 0101 can utilize alternative modes in binding its peptide ligands. According to these analyses, specific refined submotifs were also established, and their merit verified by independent sets of potential A * 0101 binding peptides. Besides providing useful insight into the nature of the interaction of the A * 0101 allele with its peptide ligands, such refined motifs should also facilitate accurate prediction of potential A * 0101-restricted peptide epitopes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Kondo, Akihiro" sort="Kondo, Akihiro" uniqKey="Kondo A" first="Akihiro" last="Kondo">Akihiro Kondo</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Sidney, John" sort="Sidney, John" uniqKey="Sidney J" first="John" last="Sidney">John Sidney</name>
</noRegion>
<name sortKey="Appella, Ettore" sort="Appella, Ettore" uniqKey="Appella E" first="Ettore" last="Appella">Ettore Appella</name>
<name sortKey="Celis, Esteban" sort="Celis, Esteban" uniqKey="Celis E" first="Esteban" last="Celis">Esteban Celis</name>
<name sortKey="Chesnut, Robert W" sort="Chesnut, Robert W" uniqKey="Chesnut R" first="Robert W." last="Chesnut">Robert W. Chesnut</name>
<name sortKey="Del Guercio, Marie France" sort="Del Guercio, Marie France" uniqKey="Del Guercio M" first="Marie-France" last="Del Guercio">Marie-France Del Guercio</name>
<name sortKey="Grey, Howard M" sort="Grey, Howard M" uniqKey="Grey H" first="Howard M." last="Grey">Howard M. Grey</name>
<name sortKey="Kubo, Ralph T" sort="Kubo, Ralph T" uniqKey="Kubo R" first="Ralph T." last="Kubo">Ralph T. Kubo</name>
<name sortKey="Sakamoto, Hiroshi" sort="Sakamoto, Hiroshi" uniqKey="Sakamoto H" first="Hiroshi" last="Sakamoto">Hiroshi Sakamoto</name>
<name sortKey="Sette, A" sort="Sette, A" uniqKey="Sette A" first="A." last="Sette">A. Sette</name>
<name sortKey="Southwood, Scott" sort="Southwood, Scott" uniqKey="Southwood S" first="Scott" last="Southwood">Scott Southwood</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D04 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D04 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:9F7F48931D968B27B427B44991B0FF1D3C92E2CF
   |texte=   Two distinct HLA-A * 0101 -specific submotifs illustrate alternative peptide binding modes
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021